MRNA

Neutral

Moderna Inc. stock (US60770K1034): Is the pivot beyond COVID vaccines now the real test?

Moderna faces the critical challenge of demonstrating that its mRNA platform can deliver successful therapies beyond its COVID-19 vaccine. This pivot ...

AD HOC NEWS 14 hours ago 0

Neutral

Moderna Impfstoff (Spikevax): Respiratory Vaccine Pivot Could Reshape mRNA Future

Moderna's Spikevax, initially known for COVID-19, is evolving into a broader respiratory vaccine, with the company focusing on combination shots for f...

AD HOC NEWS 20 hours ago 0